Get the Stockscreener App
1.36
6.25%
0.08
After Hours:
1.34
-0.02
-1.47%
Galmed Pharmaceuticals Ltd stock is traded at $1.36, with a volume of 62,054.
It is up +6.25% in the last 24 hours and down -15.00% over the past month.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
See More
Previous Close:
$1.28
Open:
$1.27
24h Volume:
62,054
Relative Volume:
0.21
Market Cap:
$7.45M
Revenue:
-
Net Income/Loss:
$-6.91M
P/E Ratio:
-0.4172
EPS:
-3.26
Net Cash Flow:
$-6.14M
1W Performance:
+7.09%
1M Performance:
-15.00%
6M Performance:
-26.09%
1Y Performance:
-60.28%
1-Day Range:
$1.26
$1.3796
1-Week Range:
$1.24
$1.3796
52-Week Range:
$1.15
$23.80
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Name
Galmed Pharmaceuticals Ltd
Sector
Industry
Phone
-
Address
-
Compare GLMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.36 | 7.01M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-22-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Feb-04-20 | Initiated | Craig Hallum | Buy |
| Jan-30-20 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-02-19 | Initiated | Canaccord Genuity | Buy |
| Dec-12-18 | Initiated | B. Riley FBR | Buy |
| Aug-02-18 | Reiterated | Maxim Group | Buy |
| Jul-13-18 | Initiated | Stifel | Buy |
| Jul-12-18 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-12-18 | Reiterated | H.C. Wainwright | Buy |
| Mar-15-18 | Upgrade | Maxim Group | Hold → Buy |
| Feb-14-18 | Downgrade | Maxim Group | Buy → Hold |
| Feb-12-18 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-17 | Initiated | ROTH Capital | Buy |
| Aug-08-17 | Reiterated | H.C. Wainwright | Buy |
| Jul-31-17 | Reiterated | Maxim Group | Buy |
| Aug-01-16 | Reiterated | Maxim Group | Buy |
| Jul-06-16 | Resumed | ROTH Capital | Buy |
| Mar-28-16 | Resumed | H.C. Wainwright | Buy |
| Jun-23-15 | Initiated | H.C. Wainwright | Buy |
| May-06-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Galmed Pharmaceuticals Ltd Stock (GLMD) Latest News
Tools to monitor Galmed Pharmaceuticals Ltd. recovery probabilityDividend Hike & AI Driven Stock Price Forecasts - Newser
Is Galmed Pharmaceuticals Ltd. stock poised for growthJuly 2025 Decliners & Daily Entry Point Alerts - Newser
How to build a dashboard for Galmed Pharmaceuticals Ltd. stock2025 Year in Review & Growth Oriented Trade Recommendations - Newser
Sentiment analysis tools applied to Galmed Pharmaceuticals Ltd.2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - Newser
What machine learning models say about Galmed Pharmaceuticals Ltd.July 2025 Highlights & Risk Managed Investment Strategies - Newser
Smart Money: A | What hedge funds are buying Galmed Pharmaceuticals Ltd.Weekly Trend Summary & Technical Confirmation Alerts - خودرو بانک
Does Galmed Pharmaceuticals Ltd. have a sustainable dividend2025 Key Highlights & Reliable Price Action Trade Plans - خودرو بانک
What hedge funds are buying Galmed Pharmaceuticals Ltd.July 2025 Movers & Long Hold Capital Preservation Tips - خودرو بانک
Momentum divergence signals in Galmed Pharmaceuticals Ltd. chartJuly 2025 Drop Watch & Reliable Price Breakout Alerts - Newser
Should value investors consider Galmed Pharmaceuticals Ltd.Quarterly Profit Report & Advanced Swing Trade Entry Plans - خودرو بانک
How to read the order book for Galmed Pharmaceuticals Ltd.July 2025 Momentum & Accurate Entry and Exit Point Alerts - Newser
Using portfolio simulators with Galmed Pharmaceuticals Ltd. includedJuly 2025 PreEarnings & Free Fast Entry Momentum Trade Alerts - Newser
Is Galmed Pharmaceuticals Ltd. a defensive stockAnalyst Upgrade & AI Powered Buy/Sell Recommendations - خودرو بانک
Is this a good reentry point in Galmed Pharmaceuticals Ltd.July 2025 Levels & Accurate Intraday Trading Signals - Newser
Applying sector rotation models to Galmed Pharmaceuticals Ltd.Market Sentiment Summary & Stepwise Entry/Exit Trade Alerts - Newser
What’s next for Galmed Pharmaceuticals Ltd. stock priceJuly 2025 Retail & Risk Managed Investment Signals - Newser
How moving averages guide Galmed Pharmaceuticals Ltd. tradingPortfolio Risk Summary & Free Technical Pattern Based Buy Signals - Newser
What’s the RSI of Galmed Pharmaceuticals Ltd. stock2025 Year in Review & Free AI Powered Buy and Sell Recommendations - خودرو بانک
What indicators show strength in Galmed Pharmaceuticals Ltd.2025 Winners & Losers & Safe Swing Trade Setup Alerts - Newser
Can a trend reversal in Galmed Pharmaceuticals Ltd. lead to recoveryWeekly Investment Report & Technical Confirmation Alerts - Newser
Ranking Galmed Pharmaceuticals Ltd. among high performing stocks via toolsMarket Trend Report & Reliable Intraday Trade Plans - Newser
Pattern recognition hints at Galmed Pharmaceuticals Ltd. upsideQuarterly Trade Review & High Win Rate Trade Tips - Newser
Is Galmed Pharmaceuticals Ltd. stock ready for a breakoutJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - Newser
Trend analysis for Galmed Pharmaceuticals Ltd. this weekStock Surge & Verified Short-Term Plans - Newser
Quantitative breakdown of Galmed Pharmaceuticals Ltd. recent move2025 Institutional Moves & Weekly Top Performers Watchlists - Newser
How to escape a deep drawdown in Galmed Pharmaceuticals Ltd.Quarterly Trade Report & Precise Trade Entry Recommendations - Newser
Can Galmed Pharmaceuticals Ltd. lead its sector in growthTrade Exit Summary & High Conviction Buy Zone Picks - خودرو بانک
Can Galmed Pharmaceuticals Ltd. ride the EV wavePrice Action & Consistent Profit Focused Trading Strategies - خودرو بانک
Does Galmed Pharmaceuticals Ltd. have strong fundamentalsQuarterly Portfolio Report & Free Fast Gain Swing Trade Alerts - خودرو بانک
What’s the outlook for Galmed Pharmaceuticals Ltd.’s sectorGDP Growth & Real-Time Sentiment Analysis - خودرو بانک
Can Galmed Pharmaceuticals Ltd. grow without dilution2025 Major Catalysts & Smart Investment Allocation Tips - خودرو بانک
Is Galmed Pharmaceuticals Ltd. stock overvalued or fairly priced2025 Geopolitical Influence & High Return Trade Opportunity Guides - خودرو بانک
Key resistance and support levels for Galmed Pharmaceuticals Ltd.Weekly Gains Report & Stepwise Entry/Exit Trade Alerts - Newser
Short Term Trend Reversal in Galmed Pharmaceuticals Ltd. PossibleBreakout Watch & Weekly Watchlist for Consistent Profits - beatles.ru
Is it time to cut losses on Galmed Pharmaceuticals Ltd.Inflation Watch & Verified Technical Signals - Newser
Galmed Pharmaceuticals Ltd Stock (GLMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):